MAPK3 and type 2 diabetes mellitus: Importantly, one study showed that the level of phosphorylated ERK1/2 was significantly reduced in islets of patients with type 2 diabetes (Ikushima et al., 2021), thus demonstrating the promotion of ERK1/2 phosphorylation on islet cell proliferation.